Moshe Zilberstein

617 total citations
27 papers, 385 citations indexed

About

Moshe Zilberstein is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Reproductive Medicine. According to data from OpenAlex, Moshe Zilberstein has authored 27 papers receiving a total of 385 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Public Health, Environmental and Occupational Health, 9 papers in Hematology and 7 papers in Reproductive Medicine. Recurrent topics in Moshe Zilberstein's work include Reproductive Biology and Fertility (8 papers), Ovarian function and disorders (6 papers) and Prenatal Screening and Diagnostics (4 papers). Moshe Zilberstein is often cited by papers focused on Reproductive Biology and Fertility (8 papers), Ovarian function and disorders (6 papers) and Prenatal Screening and Diagnostics (4 papers). Moshe Zilberstein collaborates with scholars based in United States, Israel and France. Moshe Zilberstein's co-authors include Zvi Naor, H Zakut, Markus J. Seibel, Nava Dekel, Paul Emery, Eduardo Mysler, Edit Drescher, Alberto Berman, Tsutomu Takeuchi and Philip J. Mease and has published in prestigious journals such as The Lancet, Blood and Journal of Applied Physics.

In The Last Decade

Moshe Zilberstein

27 papers receiving 374 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Moshe Zilberstein United States 11 119 104 91 78 76 27 385
Donald Adler United States 6 44 0.4× 109 1.0× 21 0.2× 107 1.4× 13 0.2× 8 296
L M Boscato Australia 7 30 0.3× 57 0.5× 21 0.2× 77 1.0× 42 0.6× 9 512
J Hustin Belgium 9 48 0.4× 109 1.0× 21 0.2× 66 0.8× 13 0.2× 17 391
S.‐T. Joseph Huang United States 7 78 0.7× 73 0.7× 8 0.1× 156 2.0× 33 0.4× 7 340
Steven M. Greenwood United States 10 139 1.2× 49 0.5× 16 0.2× 146 1.9× 19 0.3× 17 445
Hagai Kaneti Israel 12 244 2.1× 171 1.6× 12 0.1× 49 0.6× 11 0.1× 17 404
Saria Mcheik United Kingdom 6 100 0.8× 142 1.4× 20 0.2× 203 2.6× 15 0.2× 12 463
Lucas Rosa Fraga Brazil 13 43 0.4× 107 1.0× 10 0.1× 127 1.6× 77 1.0× 59 468
Jan Willem Lens Netherlands 15 314 2.6× 331 3.2× 101 1.1× 137 1.8× 7 0.1× 27 746
A Pachı̀ Italy 14 21 0.2× 62 0.6× 12 0.1× 59 0.8× 43 0.6× 66 533

Countries citing papers authored by Moshe Zilberstein

Since Specialization
Citations

This map shows the geographic impact of Moshe Zilberstein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Moshe Zilberstein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Moshe Zilberstein more than expected).

Fields of papers citing papers by Moshe Zilberstein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Moshe Zilberstein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Moshe Zilberstein. The network helps show where Moshe Zilberstein may publish in the future.

Co-authorship network of co-authors of Moshe Zilberstein

This figure shows the co-authorship network connecting the top 25 collaborators of Moshe Zilberstein. A scholar is included among the top collaborators of Moshe Zilberstein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Moshe Zilberstein. Moshe Zilberstein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Susen, Sophie, Marc Trossaërt, Moshe Zilberstein, et al.. (2025). A phase 1, open-label study to assess the pharmacokinetics, safety, and tolerability of a single intravenous injection of efanesoctocog alfa in adults with type 2N or type 3 von Willebrand disease. Journal of Thrombosis and Haemostasis. 24(1). 79–87. 2 indexed citations
2.
Lissitchkov, Toshko, et al.. (2023). Pharmacokinetics of recombinant factor VIII in adults with severe hemophilia A: fixed-sequence single-dose study of octocog alfa, rurioctocog alfa pegol, and efanesoctocog alfa. Research and Practice in Thrombosis and Haemostasis. 7(4). 100176–100176. 8 indexed citations
3.
4.
D’Sa, Shirley, Josephine M. I. Vos, Wilma Barcellini, et al.. (2023). Safety, tolerability, and activity of the active C1s antibody riliprubart in cold agglutinin disease: a phase 1b study. Blood. 143(8). 713–720. 12 indexed citations
5.
Gabay, Cem, Gerd R Burmester, Vibeke Strand, et al.. (2020). Sarilumab and adalimumab differential effects on bone remodelling and cardiovascular risk biomarkers, and predictions of treatment outcomes. Arthritis Research & Therapy. 22(1). 70–70. 32 indexed citations
9.
Zilberstein, Moshe. (2004). Mining the human genome for new health therapies. Fertility and Sterility. 81. 4–8. 2 indexed citations
10.
Bar‐Ami, Shalom, Markus J. Seibel, Kenneth E. Pierce, & Moshe Zilberstein. (2003). Preimplantation genetic diagnosis for a couple with recurrent pregnancy loss and triploidy. Birth Defects Research Part A Clinical and Molecular Teratology. 67(11). 946–950. 6 indexed citations
11.
Zilberstein, Moshe, et al.. (1997). Umbilical-cord-blood banking: lessons learned from gamete donation. The Lancet. 349(9052). 642–643. 12 indexed citations
12.
Zilberstein, Moshe & Markus J. Seibel. (1997). Transvaginal Amniotic Puncture for Cytogenetic Evaluation of Missed Abortions. Gynecologic and Obstetric Investigation. 44(4). 217–220. 2 indexed citations
13.
Pierce, Kenneth E., et al.. (1997). Preimplantation development of mouse and human embryos biopsied at cleavage stages using a modified displacement technique. Human Reproduction. 12(2). 351–356. 27 indexed citations
14.
Seibel, Markus J., et al.. (1994). Gender distribution—not sex selection. Human Reproduction. 9(4). 569–569. 6 indexed citations
15.
Verp, Marion S., et al.. (1993). γδ T cells in human decidua. American Journal of Obstetrics and Gynecology. 168(3). 831–836. 15 indexed citations
16.
Zilberstein, Moshe, et al.. (1992). High transfer-efficiency microsurface acoustic wave directional couplers. Journal of Applied Physics. 72(12). 5561–5564. 1 indexed citations
17.
Dekel, Nava, et al.. (1985). Characterization of the maturational changes induced by a GnRH analogue in the rat ovarian follicle. Reproduction. 75(2). 461–466. 21 indexed citations
18.
Naor, Zvi, Moshe Zilberstein, H Zakut, & Nava Dekel. (1984). Gonadotropin releasing hormone: Regulation of phospholipid turnover and prostaglandin production in ovarian granulosa cells. Life Sciences. 35(4). 389–398. 8 indexed citations
20.
Zilberstein, Moshe, H Zakut, & Zvi Naor. (1983). Coincidence of down-regulation and desensitization in pituitary gonadotrophs stimulated by gonadotropin releasing hormone. Life Sciences. 32(6). 663–669. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026